![]() |
Volumn 170, Issue 3, 2001, Pages 647-651
|
Transforming growth factor-β2 antibody attenuates fibrosis in the experimental diabetic rat kidney
a
a
a
a
a
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALBUMIN;
COLLAGEN TYPE 1;
GLUCOSE;
IMMUNOGLOBULIN G4;
MONOCLONAL ANTIBODY;
MONOCLONAL ANTIBODY CAT 152;
NEUTRALIZING ANTIBODY;
PLACEBO;
PROCOLLAGEN C PROTEINASE;
SCLEROPROTEIN;
STREPTOZOCIN;
TRANSFORMING GROWTH FACTOR BETA;
TRANSFORMING GROWTH FACTOR BETA2;
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ARTICLE;
ATTENUATION;
COLLAGEN SYNTHESIS;
CONTROLLED STUDY;
DIABETIC NEPHROPATHY;
EXPERIMENTAL DIABETES MELLITUS;
FEMALE;
FIBROGENESIS;
FOOD INTAKE;
KIDNEY CORTEX;
KIDNEY FIBROSIS;
KIDNEY MASS;
NONHUMAN;
PATHOGENICITY;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
RAT;
STREPTOZOCIN DIABETES;
URINARY EXCRETION;
WESTERN BLOTTING;
ALBUMINURIA;
ANIMALS;
ANTIBODIES, MONOCLONAL;
BODY WEIGHT;
DIABETES MELLITUS, EXPERIMENTAL;
DIABETIC NEPHROPATHIES;
FEMALE;
FIBROSIS;
KIDNEY;
KIDNEY GLOMERULUS;
ORGAN SIZE;
PEPTIDE FRAGMENTS;
PROCOLLAGEN;
RATS;
RATS, WISTAR;
TRANSFORMING GROWTH FACTOR BETA;
TRANSFORMING GROWTH FACTOR BETA2;
|
EID: 0034827951
PISSN: 00220795
EISSN: None
Source Type: Journal
DOI: 10.1677/joe.0.1700647 Document Type: Article |
Times cited : (85)
|
References (27)
|